Healthy Inc > Blog > B2B pharma marketplace
Posted on:

What is the use of Azithromycin dispersible tablets?

In the pharmaceutical industry, Azithromycin Dispersible Tablets (typically 100 mg or 250 mg) are a specialized pediatric formulation of the macrolide antibiotic class. As a pharmacist, I view the dispersible format as a critical advancement in “patient-centric” medicine—ensuring that children receive the precise, potent dose of a broad-spectrum antibiotic without the struggle of swallowing large pills or the stability issues often found in liquid suspensions.

Primary Clinical Uses

  • Upper Respiratory Tract Infections (URTI): Highly effective for tonsillitis, pharyngitis, and acute sinusitis.

  • Lower Respiratory Tract Infections (LRTI): A first-line treatment for community-acquired pneumonia and acute bacterial exacerbations of bronchitis.

  • Acute Otitis Media: The primary choice for middle ear infections in children due to its high tissue penetration.

  • Skin and Soft Tissue Infections: Used for uncomplicated infections caused by Staphylococcus aureus or Streptococcus pyogenes.

Mechanism of Action

Azithromycin works by binding to the 50S ribosomal subunit of susceptible microorganisms. This action interferes with microbial protein synthesis by inhibiting the transpeptidation/translocation step.

What makes Azithromycin unique from a pharmacokinetic standpoint is its extensive tissue distribution. It concentrates within lysosomes and white blood cells (phagocytes), which then “transport” the drug directly to the site of infection. This results in high local concentrations and allows for a convenient once-daily dosing schedule.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, the dispersible tablet is a high-tech solution for global health:

  • Instant Disintegration: As a WHO-GMP standard, these tablets are formulated to disintegrate in less than 60 seconds in a teaspoon of water, forming a smooth suspension that is easy for infants and children to swallow.

  • Taste-Masking Excellence: Azithromycin API is notoriously bitter. Our formulation involves advanced taste-masking technology and fruit flavors (like strawberry or mango) to ensure pediatric compliance and prevent “spit-ups.”

  • Stability in Transit: Unlike liquid syrups which require bulky glass bottles and have shorter shelf lives once reconstituted, dispersible tablets are lightweight and highly stable. We utilize Alu-Alu blister packaging to protect the API from moisture and light, making it ideal for export to Zone IVb climates.

  • Global Market Demand: These tablets are essential for B2B distributors and international NGO tenders (like UNICEF) catering to pediatric health in Africa, Southeast Asia, and the Middle East.

Azithromycin Dispersible Tablet

Posted on:

What is Azatioprine used to treat?

In the pharmaceutical industry, Azathioprine tablets (commonly 50 mg) are classified as a potent immunosuppressant and a prodrug of 6-mercaptopurine. As a pharmacist, I view Azathioprine as a critical “steroid-sparing” agent, allowing clinicians to reduce long-term corticosteroid use while maintaining control over the immune system.

Primary Clinical Uses

  • Organ Transplant Rejection: Used as a mainstay adjunctive therapy to prevent the rejection of kidney, heart, and liver transplants, typically in combination with other immunosuppressants.

  • Rheumatoid Arthritis (RA): Indicated for patients with severe, active RA who have not responded to conventional first-line Disease-Modifying Anti-Rheumatic Drugs (DMARDs).

  • Inflammatory Bowel Disease (IBD): Widely used to maintain remission in patients with Crohn’s Disease and Ulcerative Colitis.

  • Autoimmune Disorders: Effective in treating Systemic Lupus Erythematosus (SLE), autoimmune hepatitis, and Myasthenia Gravis.

Mechanism of Action

Azathioprine is a purine antimetabolite. Once ingested, it is rapidly converted into 6-mercaptopurine (6-MP). It acts by interfering with DNA and RNA synthesis within rapidly dividing cells, particularly T-lymphocytes and B-lymphocytes. By inhibiting the proliferation of these immune cells, Azathioprine suppresses the body’s autoimmune attack or the rejection response against a donor organ.

Technical Note: The metabolism of Azathioprine depends on the enzyme TPMT (Thiopurine Methyltransferase). As a pharmacist, I always emphasize that patients should ideally be screened for TPMT activity before starting therapy to avoid severe bone marrow toxicity.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Azathioprine is a high-sensitivity molecule requiring rigorous quality standards:

  • Cytotoxic Handling: Azathioprine is a potent substance. In our manufacturing processes, we adhere to strict containment protocols and WHO-GMP standards to prevent cross-contamination and ensure worker safety.

  • Stability & Coating: The tablets are typically film-coated to protect the active ingredient from light and to prevent dust exposure during handling. We ensure the coating provides a robust barrier for long-term stability in export conditions.

  • Global Export Niche: Azathioprine is a vital product for B2B marketplaces and hospital supply chains catering to oncology and transplant centers in the CIS, Middle East, and Africa.

  • Documentation: We provide full CTD/eCTD Dossiers, including stability data for Zone IVb, to facilitate registration in international markets where chronic disease management is expanding.

Azathioprine Tablets

Posted on:

What are Atorvastatin Tablets used for?

In the pharmaceutical industry, Atorvastatin Calcium tablets (commonly manufactured in 10 mg, 20 mg, 40 mg, and 80 mg strengths) are the premier HMG-CoA reductase inhibitors, more commonly known as “statins.” As a pharmacist, I view Atorvastatin as a cornerstone of lipid-lowering therapy due to its superior ability to reduce LDL cholesterol and provide significant pleiotropic benefits for cardiovascular stability.

Primary Clinical Uses

  • Hypercholesterolemia: Indicated as an adjunct to diet to reduce elevated total cholesterol, LDL-C (“bad” cholesterol), and triglycerides, while increasing HDL-C (“good” cholesterol).

  • Prevention of Cardiovascular Disease: Used to reduce the risk of myocardial infarction (heart attack), stroke, and revascularization procedures in patients with or without clinically evident coronary heart disease.

  • Dysbetalipoproteinemia: Effective for patients with primary dysbetalipoproteinemia who do not respond adequately to diet.

  • Secondary Prevention: Indicated for patients with established coronary heart disease to reduce the risk of non-fatal myocardial infarction and fatal/non-fatal stroke.

Mechanism of Action

Atorvastatin works by selectively and competitively inhibiting HMG-CoA reductase, the rate-limiting enzyme that converts 3-hydroxy-3-methylglutaryl-coenzyme A to mevalonate, a precursor of sterols, including cholesterol. By reducing hepatic cholesterol synthesis, it triggers an up-regulation of LDL receptors on the surface of liver cells, which enhances the uptake and catabolism of LDL from the blood.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Atorvastatin is a high-demand, technically demanding molecule:

  • Amorphous vs. Crystalline Form: As a WHO-GMP manufacturer, we carefully control the physical form of the API. While the crystalline form is often preferred for its stability, the formulation must be optimized to ensure high bioavailability and consistent dissolution rates.

  • Stability & Oxidation: Atorvastatin is sensitive to heat, light, and moisture. We utilize Alu-Alu blister packaging and include antioxidants in the formulation to ensure a stable 24-month shelf life, especially for export to Zone IVb (hot and humid) regions.

  • Dose Versatility: We manufacture the full range of strengths (10 mg to 80 mg) to allow for the “high-intensity statin therapy” required for high-risk cardiac patients.

  • Global Market Access: Atorvastatin is one of the most exported chronic care medications. Our Mumbai-based hub provides full CTD/eCTD Dossier support for registration in international markets across Africa, the CIS, and Southeast Asia.

Atorvastatin Tablets

Posted on:

What is atenolol chlorthalidone tablets used for?

In the pharmaceutical industry, the combination of Atenolol and Chlorthalidone is a highly effective fixed-dose combination (FDC) used as a second-line or synergistic therapy for hypertension. As a pharmacist, I view this pairing as a strategic “volume and rate” approach: Atenolol manages the heart’s workload, while Chlorthalidone manages the body’s fluid volume.

Primary Clinical Uses

  • Essential Hypertension: Specifically indicated for patients whose blood pressure is not adequately controlled by monotherapy.

  • Cardiovascular Risk Reduction: By maintaining long-term blood pressure control, it significantly reduces the risk of stroke, heart failure, and myocardial infarction.

  • Simplifying Dosage Regimens: It improves patient compliance by combining two classes of medication into a single daily tablet.

Mechanism of Action

This combination works through two distinct physiological pathways:

Atenolol (Beta-1 Selective Blocker): It targets the $\beta_1$-adrenergic receptors in the heart. By blocking these receptors, it decreases heart rate and cardiac output, effectively reducing the force of contraction and the heart’s demand for oxygen.

Chlorthalidone (Thiazide-like Diuretic): It inhibits sodium and chloride reabsorption in the distal convoluted tubule of the kidney. This increases the excretion of sodium and water, reducing the overall plasma volume and venous return to the heart.

Unlike standard Hydrochlorothiazide, Chlorthalidone has a significantly longer half-life (approx. 40–60 hours), providing more consistent 24-hour blood pressure control, which is particularly beneficial for preventing early morning blood pressure spikes.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, this FDC is a high-volume essential for chronic care portfolios:

  • Stability of Active Ingredients: As a WHO-GMP manufacturer, we ensure the chemical compatibility of the Atenolol and Chlorthalidone within the tablet matrix. We monitor for degradation products to ensure a stable 24-month shelf life.

  • Hygroscopic Protection: Chlorthalidone can be sensitive to environmental moisture. We utilize PVC/PVDC or Alu-Alu blister packaging to protect the integrity of the formulation, especially for export to hot and humid Zone IVb climates.

  • Global Export Reach: Hypertension is a global priority. This combination is a staple for B2B distributors and government health tenders in regions like Southeast Asia, Africa, and the Middle East.

  • Regulatory Documentation: We provide comprehensive CTD/eCTD Dossiers and comparative dissolution studies to assist our international partners in the registration process.

Atenolol with Chlorthalidone tablets.

Posted on:

What is an atenolol tablet good for?

In the pharmaceutical industry, Atenolol tablets (typically 25 mg, 50 mg, and 100 mg) are a foundational Cardioselective Beta-Blocker ($\beta_1$-selective). As a pharmacist, I view Atenolol as a “precision tool” for cardiovascular management because it specifically targets the heart’s receptors while minimizing the respiratory side effects often seen with older, non-selective beta-blockers.

Primary Clinical Uses

  • Hypertension (High Blood Pressure): It is used to lower blood pressure, which helps prevent long-term complications such as strokes, heart failure, and kidney problems.

  • Angina Pectoris: Indicated for the long-term management of chest pain by reducing the oxygen demand of the heart muscle during physical activity or stress.

  • Acute Myocardial Infarction: Administered to stable patients post-heart attack to reduce cardiovascular mortality and the risk of re-infarction.

  • Cardiac Arrhythmias: Used to control heart rate in conditions like atrial fibrillation or supraventricular tachycardia.

Mechanism of Action

Atenolol is a competitive antagonist of $\beta_1$-adrenergic receptors, which are primarily located in the heart. By blocking the effects of epinephrine (adrenaline) and norepinephrine, it:

Reduces Heart Rate (Negative Chronotropic effect): Slows the resting and exercise heart rate.

Decreases Contractility (Negative Inotropic effect): Reduces the force with which the heart muscle pumps.

Lowers Blood Pressure: By reducing cardiac output and inhibiting the release of renin from the kidneys.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Atenolol is a high-demand, stable molecule that is a staple for B2B export portfolios:

  • Cardioselectivity Standards: As a WHO-GMP manufacturer, we ensure that our formulation maintains strict $\beta_1$ selectivity. This is a critical selling point for doctors who need to treat hypertensive patients with mild underlying respiratory issues (where non-selective blockers like Propranolol are contraindicated).

  • Stability & Shelf Life: Atenolol is a chemically robust molecule. We provide it in various packaging formats (blister/strip) designed to withstand the climatic conditions of Zone IVb (hot and humid), ensuring a reliable 36-month shelf life for our export partners.

  • Global Market Demand: Given that cardiovascular disease is a leading global health concern, Atenolol remains a high-volume item for international tenders and B2B marketplaces in Africa, the Middle East, and Southeast Asia.

  • Regulatory Documentation: We provide full CTD/eCTD Dossiers and Comparative Dissolution Profiles to ensure our partners can easily register the product with their local health authorities (e.g., NAFDAC, PPB, TFDA).

 

Posted on:

What is the use of artesunate and amodiaquine tablets?

In the pharmaceutical industry, the combination of Artesunate and Amodiaquine (AS+AQ) is a cornerstone of Artemisinin-based Combination Therapy (ACT). As a pharmacist, I view this fixed-dose combination (FDC) as a vital public health tool, specifically engineered to combat Plasmodium falciparum malaria by providing a “one-two punch” that eliminates parasites at different stages of their life cycle.

Primary Clinical Uses

  • Treatment of Uncomplicated Malaria: Indicated as a first-line therapy for acute, uncomplicated malaria infections, especially in regions with high chloroquine resistance.

  • Pediatric and Adult Populations: Available in specific weight-based strengths (e.g., 25/67.5 mg, 50/135 mg, and 100/270 mg) to ensure precise dosing and reduce the risk of sub-therapeutic treatment.

  • Rapid Parasite Clearance: Used to achieve high cure rates (typically >95%) and to prevent the progression of the disease into severe, life-threatening malaria.

Mechanism of Action

This FDC utilizes two distinct chemical classes to ensure maximum parasiticidal effect:

Artesunate (Artemisinin Derivative): It acts rapidly by reacting with the iron in the parasite’s heme to generate reactive free radicals. These radicals cause widespread damage to the parasite’s cell membranes and essential proteins, resulting in a rapid “knockdown” of the parasite load.

Amodiaquine (4-Aminoquinoline): It acts as a long-acting blood schizontocide. It interferes with the parasite’s ability to detoxify heme (converting it into non-toxic hemozoin). The resulting accumulation of toxic free heme leads to the death of any parasites that survived the initial Artesunate burst.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, AS+AQ is a technically sensitive product that demands high-tier quality control:

  • Bilayer Tablet Technology: Because Artesunate is highly sensitive to moisture and can interact with the Amodiaquine salt, we often utilize bilayer compression. This physical separation within a single tablet enhances the stability and shelf-life of the product.

  • Hygroscopic Protection: Artesunate is moisture-labile. As a WHO-GMP manufacturer, we utilize Alu-Alu blister packaging to provide a superior moisture barrier, ensuring the tablets remain stable in Zone IVb (hot and humid) climates.

  • Global Health Compliance: This combination is a staple for international health tenders (e.g., Global Fund, USAID). Our Mumbai-based facility is optimized for high-capacity production with full CTD/eCTD Dossier support for rapid international registration.

  • Safety Monitoring: We adhere to strict API standards to minimize the risk of rare adverse effects like neutropenia or hepatotoxicity, ensuring the product is as safe as it is effective.

Artesunate Amodiaquine Tablets

Posted on:

What is the use of artesunate mefloquine?

In the pharmaceutical industry, the combination of Artesunate and Mefloquine (ASMQ) is a high-efficacy Artemisinin-based Combination Therapy (ACT). As a pharmacist, I view this fixed-dose combination (FDC) as a critical therapeutic option for regions with multi-drug resistant malaria, as it pairs the fastest-acting antimalarial with one of the longest-lasting ones.

Primary Clinical Uses

  • Treatment of Uncomplicated Malaria: Primarily indicated for the treatment of acute, uncomplicated malaria infections caused by Plasmodium falciparum.

  • Multi-Drug Resistant Regions: It is a first-line therapy in areas where parasites have developed resistance to other ACTs (such as Southeast Asia and parts of South America).

  • Prevention of Transmission: By rapidly clearing the parasite load, it reduces the reservoir of infection within a community, helping to curb the spread of malaria.

Mechanism of Action

This combination offers a “synergistic blockade” against the malaria parasite:

Artesunate (Fast-Acting): Quickly reduces the parasite biomass by generating reactive free radicals that disrupt the parasite’s cell membranes and essential proteins.

Mefloquine (Long-Acting): A quinoline methanol derivative that acts by interfering with the parasite’s ability to detoxify heme (the byproduct of hemoglobin digestion). Its long half-life ensures that any remaining parasites are eliminated over several weeks, preventing recrudescence (relapse).

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, ASMQ is a technically sophisticated product that demands high quality standards:

  • Stability & Hygroscopicity: Artesunate is highly sensitive to moisture. As a WHO-GMP manufacturer, we utilize Alu-Alu blister packaging and strictly controlled, low-humidity production environments to prevent degradation during export to tropical Zone IVb climates.

  • Side Effect Mitigation: Mefloquine is sometimes associated with neurological side effects. By formulating it as an FDC with Artesunate, we ensure precise dosing which helps maintain the therapeutic window and improves the safety profile compared to loosely combined monotherapies.

  • Fixed-Dose Combination (FDC) Technology: We specialize in the complex formulation required to keep both APIs stable within a single tablet, ensuring consistent dissolution and bioavailability for both components.

  • Global Export Hub: Operating from Mumbai, we provide the CTD/eCTD Dossiers and stability data required for registration in international markets, supporting B2B partners and government tenders in malaria-endemic regions.

Artesunate Mefloquine Tablets

Posted on:

What is the use of artesunate sulfadoxine pyrimethamine tablet?

In the pharmaceutical industry, the combination of Artesunate and Sulfadoxine-Pyrimethamine (AS+SP) is a powerful Artemisinin-based Combination Therapy (ACT). As a pharmacist, I characterize this fixed-dose combination (FDC) as a strategic multi-target treatment designed to clear parasites rapidly while providing a long-acting “chemical umbrella” to prevent the recurrence of infection.

Primary Clinical Uses

  • Treatment of Uncomplicated Malaria: Indicated for the treatment of acute, uncomplicated malaria infections caused by Plasmodium falciparum in areas where the parasite remains sensitive to the SP component.

  • Rapid Parasite Clearance: The Artesunate component ensures that the parasite load in the blood is reduced within hours, preventing the onset of severe malaria.

  • Prevention of Recrudescence: The long-acting Sulfadoxine and Pyrimethamine components remain in the bloodstream for weeks to kill any residual parasites.

  • Intermittent Preventive Treatment (IPT): In specific high-risk regions, this combination is sometimes utilized in pregnancy (IPTp) or for infants (IPTi) to reduce the burden of malaria.

Mechanism of Action

This combination employs a dual-mechanism approach to ensure parasitic death:

Artesunate (Fast-Acting): Generates reactive free radicals that damage the parasite’s proteins and membranes by reacting with the iron in the parasite’s food vacuole. It targets the asexual erythrocytic stages.

Sulfadoxine & Pyrimethamine (Long-Acting): These act as sequential inhibitors of folic acid synthesis. Sulfadoxine inhibits the enzyme dihydropteroate synthase, while Pyrimethamine inhibits dihydrofolate reductase. Since parasites must synthesize their own folates for DNA production, this blockade effectively halts their replication.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, AS+SP is a specialized product requiring high-tier regulatory compliance:

  • Stability Management: Artesunate is highly sensitive to moisture and heat. As a WHO-GMP manufacturer, we utilize Alu-Alu blister packaging and low-humidity manufacturing zones to protect the integrity of the Artesunate API during storage and transit.

  • Fixed-Dose Precision: We ensure that the ratio of Sulfadoxine to Pyrimethamine is precisely 20:1 (typically 500 mg/25 mg) to maintain the synergistic effect while minimizing potential side effects.

  • Global Export Niche: This combination is a staple for B2B distributors and government health tenders in sub-Saharan Africa and Southeast Asia. Our Mumbai hub is optimized for high-capacity production to meet international public health demands.

  • Regulatory Dossiers: We provide comprehensive CTD/eCTD documentation and stability data for Zone IVb to facilitate smooth registration in malaria-endemic international markets.

Artesunate Sulphadoxine Pyrimethamine Tablets

Posted on:

What is the use of artesunate sulfadoxine pyrimethamine tablet?

In the pharmaceutical industry, the combination of Artesunate and Sulfadoxine-Pyrimethamine (AS+SP) is a powerful Artemisinin-based Combination Therapy (ACT). As a pharmacist, I characterize this fixed-dose combination (FDC) as a strategic multi-target treatment designed to clear parasites rapidly while providing a long-acting “chemical umbrella” to prevent the recurrence of infection.

Primary Clinical Uses

  • Treatment of Uncomplicated Malaria: Indicated for the treatment of acute, uncomplicated malaria infections caused by Plasmodium falciparum in areas where the parasite remains sensitive to the SP component.

  • Rapid Parasite Clearance: The Artesunate component ensures that the parasite load in the blood is reduced within hours, preventing the onset of severe malaria.

  • Prevention of Recrudescence: The long-acting Sulfadoxine and Pyrimethamine components remain in the bloodstream for weeks to kill any residual parasites.

  • Intermittent Preventive Treatment (IPT): In specific high-risk regions, this combination is sometimes utilized in pregnancy (IPTp) or for infants (IPTi) to reduce the burden of malaria.

  • Mechanism of Action

This combination employs a dual-mechanism approach to ensure parasitic death:

Artesunate (Fast-Acting): Generates reactive free radicals that damage the parasite’s proteins and membranes by reacting with the iron in the parasite’s food vacuole. It targets the asexual erythrocytic stages.

Sulfadoxine & Pyrimethamine (Long-Acting): These act as sequential inhibitors of folic acid synthesis. Sulfadoxine inhibits the enzyme dihydropteroate synthase, while Pyrimethamine inhibits dihydrofolate reductase. Since parasites must synthesize their own folates for DNA production, this blockade effectively halts their replication.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, AS+SP is a specialized product requiring high-tier regulatory compliance:

  • Stability Management: Artesunate is highly sensitive to moisture and heat. As a WHO-GMP manufacturer, we utilize Alu-Alu blister packaging and low-humidity manufacturing zones to protect the integrity of the Artesunate API during storage and transit.

  • Fixed-Dose Precision: We ensure that the ratio of Sulfadoxine to Pyrimethamine is precisely 20:1 (typically 500mg/25mg) to maintain the synergistic effect while minimizing potential side effects.

  • Global Export Niche: This combination is a staple for B2B distributors and government health tenders in sub-Saharan Africa and Southeast Asia. Our Mumbai hub is optimized for high-capacity production to meet international public health demands.

  • Regulatory Dossiers: We provide comprehensive CTD/eCTD documentation and stability data for Zone IVb to facilitate smooth registration in malaria-endemic international markets.

 

Posted on:

What is the use of artesunate tablet?

In the pharmaceutical industry, Artesunate tablets (commonly 50 mg, 100 mg, or 200 mg) are a semi-synthetic derivative of artemisinin. As a pharmacist, I view Artesunate as one of the most powerful and fast-acting antimalarial agents available, serving as the cornerstone of modern malaria therapy to prevent the progression of the disease to severe or fatal stages.

Primary Clinical Uses

  • Uncomplicated Malaria: Indicated for the treatment of acute, uncomplicated malaria caused by Plasmodium falciparum.

  • ACT Combination Therapy: Following WHO guidelines, Artesunate is almost always used in Artemisinin-based Combination Therapy (ACT). It is paired with longer-acting partner drugs (like Amodiaquine, Mefloquine, or Sulfadoxine-Pyrimethamine) to ensure a complete cure and prevent resistance.

  • Step-down Therapy: Used as an oral follow-up treatment after an initial course of parenteral (injectable) artesunate for severe malaria, once the patient can tolerate oral medication.

  • Chloroquine-Resistant Malaria: Effective in regions where the parasite has developed high levels of resistance to traditional antimalarials.

Mechanism of Action

Artesunate is a “prodrug” that is rapidly converted into its active metabolite, dihydroartemisinin (DHA). It acts by reacting with the iron in the parasite’s heme (from digested hemoglobin) to create reactive free radicals. These radicals cause extensive damage to the parasite’s proteins and membranes, specifically targeting the asexual erythrocytic stages, leading to a rapid reduction in parasite biomass.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Artesunate is a high-priority, technically sensitive molecule:

  • Hydrolytic Stability: Artesunate is highly sensitive to moisture and can easily degrade into DHA in the presence of humidity. As a WHO-GMP manufacturer, we utilize strictly controlled, low-humidity environments and Alu-Alu blister packaging to ensure product stability for 24 months.

  • Fixed-Dose Combination (FDC) Expertise: We specialize in the complex formulation of Artesunate with partner drugs, ensuring that each API remains stable and bioavailable within a single tablet matrix.

  • Global Health Tenders: Artesunate is a staple for international NGOs, UNICEF, and the Global Fund. Our Mumbai facility is optimized for the high-volume production and the rigorous CTD/eCTD documentation required for these global contracts.

  • Quality Assurance: Each batch is tested against BP/USP/IP standards to ensure precise potency, which is critical in preventing the emergence of drug-resistant malaria strains.

Artesunate Tablets

Add to cart